CD24 and squamous cell carcinoma: CD24 immunopositivity was noted in 43.93% (29/69) of well-differentiated squamous cell carcinoma (WDSCC) and 44.89% (22/49) of moderately differentiated squamous cell carcinoma (MDSCC) + PDSCC (Table 2).